COSCIENS Biopharma Inc. Financial Assets At Fair Value Through Profit Or Loss
COSCIENS Biopharma Inc. (CSCIF) had Financial Assets At Fair Value Through Profit Or Loss of $0 as of 2017-12-31, per its 20-F filed 2019-04-01.
Discontinued › Notes
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss · last filed 2019-04-01
- 2017-12-31: Financial Assets At Fair Value Through Profit Or Loss $0.00.
- 2016-12-31: Financial Assets At Fair Value Through Profit Or Loss $0.00.
| Period end | Financial Assets At Fair Value Through Profit Or Loss |
|---|---|
| 2017-12-31 | $0.00 20-F · filed 2019-04-01 |
| 2016-12-31 | $0.00 20-F · filed 2018-03-28 |